Facebook tracking pixel
S10.AI
ICD-10-CM · I50.33GeneralSystemic

Acute on Chronic Heart Failure with Preserved Ejection Fraction

Understanding Acute on Chronic Heart Failure with Preserved Ejection Fraction (HFpEF), also known as Diastolic Heart Failure with Preserved Ejection Fraction? This resource provides essential information for healthcare professionals on clinical documentation and medical coding related to HFpEF diagnosis, treatment, and management. Learn about key symptoms, diagnostic criteria, and best practices for accurate clinical documentation to support proper medical coding and billing for Acute on Chronic Heart Failure with Preserved Ejection Fraction.

Also known as
HFpEFDiastolic Heart Failure with Preserved Ejection Fraction
Definition

Worsening of chronic heart failure where the heart's pumping ability is preserved but filling is impaired.

Clinical signs

Shortness of breath, fatigue, swelling in legs, rapid weight gain, lung congestion.

Common settings

Hospitalization, outpatient cardiology clinic, primary care follow-up.

Related Codes

ICD-10 Code Families

Complete code families applicable to I50.33

I50.31
Acute on chronic diastolic heart failure
I50.33
Acute on chronic combined systolic and diastolic heart failure
I11.0
Hypertensive heart disease with heart failure
Code Comparison

When to use each related code

DescriptionWhen to use
Heart failure with normal pumping ability but stiff heart muscle.Acute exacerbation of chronic heart failure with preserved ejection fraction (LVEF > 50%).
Heart failure with reduced pumping ability.Heart failure with reduced ejection fraction (HFrEF/LVEF < 40%), systolic dysfunction. Use when the heart doesn't pump well.
Heart failure with mildly reduced pumping ability.Heart failure with mid-range ejection fraction (HFmrEF/LVEF 40-49%). Use when LVEF is between 40% and 49%.
Documentation

Best-practice checklist

  • Document acute exacerbation of chronic HFpEF.
  • Confirm preserved ejection fraction (>=50%).
  • Specify symptoms and signs of heart failure.
  • Note NYHA functional class if applicable.
  • Document comorbid conditions and medications.
Coding & Audit Risks

Common pitfalls to avoid

Unspecified HF Type

Coding acute on chronic HFpEF without specifying the chronic component can lead to undercoding and lost revenue.

Comorbidity Capture

Failing to document and code associated comorbidities like hypertension or diabetes with HFpEF impacts risk adjustment.

Acute vs. Chronic Confusion

Misinterpreting acute on chronic HFpEF as simply acute or chronic HF can lead to inaccurate coding and claims denial.

Mitigation

Best-practice tips

  • 01Document acute decompensation triggers: infection, arrhythmia, ischemia. Code I50.1, I11.0, I20.9
  • 02Specify HFpEF symptoms: dyspnea, fatigue, edema. Improve CDI for accurate risk adjustment.
  • 03Echocardiogram confirms preserved EF >50% with diastolic dysfunction for HFpEF diagnosis. I42.0
  • 04Optimize medications: diuretics for congestion, control hypertension, diabetes, and comorbidities.
  • 05Patient education on fluid/salt restriction, medication adherence, symptom monitoring for compliance.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify HF symptoms: dyspnea, edema, fatigue

  2. 2

    LVEF >=50% confirmed by echo/imaging?

  3. 3

    Prior HF diagnosis or chronic cardiac condition?

  4. 4

    Assess for acute triggers: infection, ischemia, arrhythmia

Documentation Template

Ready-to-paste narrative

Patient presents with acute on chronic heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure with preserved ejection fraction.  The patient reports symptoms consistent with acute decompensated heart failure, including dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, and lower extremity edema.  Physical exam reveals elevated jugular venous pressure, bibasilar crackles on lung auscultation, and S3 gallop.  The patient's left ventricular ejection fraction (LVEF) is greater than or equal to 50% based on recent echocardiography, confirming preserved systolic function.  Medical history includes long-standing hypertension, type 2 diabetes mellitus, and obesity, all of which are contributing risk factors for HFpEF.  Diagnosis of acute on chronic diastolic heart failure is made based on the constellation of clinical symptoms, signs, and preserved LVEF.  Treatment plan includes optimization of diuretic therapy for fluid management, titration of antihypertensive medications to control blood pressure, and patient education regarding sodium restriction and fluid management strategies.  Close monitoring of symptoms, fluid status, and electrolyte levels is essential.  Referral to a cardiologist for further evaluation and management is recommended. Differential diagnosis includes other causes of dyspnea such as chronic obstructive pulmonary disease (COPD) and pulmonary embolism, which were ruled out based on clinical presentation and diagnostic testing.  The patient's prognosis is dependent on adherence to the treatment plan and management of underlying comorbidities.  ICD-10 code I50.31 for acute on chronic diastolic heart failure is documented.
FAQs

Common questions and answers

What are the key differentiating factors in diagnosing Acute on Chronic Heart Failure with Preserved Ejection Fraction (HFpEF) compared to HFrEF?+

Differentiating Acute on Chronic Heart Failure with Preserved Ejection Fraction (HFpEF) from Heart Failure with Reduced Ejection Fraction (HFrEF) hinges on assessing left ventricular ejection fraction (LVEF). HFpEF is characterized by a preserved LVEF (>=50%), meaning the heart's pumping ability is maintained, but the left ventricle's ability to relax and fill during diastole is impaired. This contrasts with HFrEF, where the LVEF is reduced (<40%), indicating the heart struggles to pump effectively. While both present with similar symptoms like dyspnea and fatigue, the underlying pathophysiology and subsequent management differ significantly. Consider implementing diagnostic strategies that incorporate echocardiography to accurately measure LVEF and assess diastolic function. Explore how BNP/NT-proBNP levels can aid in distinguishing between these two forms of heart failure, recognizing that elevated levels are common in both but can be particularly insightful in acute presentations. Learn more about the specific therapeutic approaches for HFpEF, which often focus on symptom management and comorbidity control, unlike HFrEF treatments that target improving contractility.

How do I effectively manage acute exacerbations of HFpEF in patients with multiple comorbidities, considering the complex interplay of medications?+

Managing acute exacerbations of Heart Failure with Preserved Ejection Fraction (HFpEF) in patients with multiple comorbidities requires a nuanced approach, given the potential for drug interactions and contraindications. Prioritize optimizing fluid status through careful diuretic titration, recognizing that over-diuresis can be detrimental in these patients. Address common comorbidities like hypertension, atrial fibrillation, and chronic kidney disease, as these conditions can significantly impact HFpEF management. Consider implementing a multidisciplinary approach, involving a cardiologist, nephrologist, and other specialists as needed, to ensure comprehensive care. Explore how to tailor medication regimens to the individual patient's needs, cautiously balancing the benefits of each drug against its potential risks, particularly in the presence of renal dysfunction. Learn more about the role of non-pharmacological interventions, including lifestyle modifications and patient education, in long-term HFpEF management.

What are the best evidence-based strategies for preventing hospital readmissions in patients recently discharged after an acute episode of HFpEF?+

Preventing hospital readmissions for patients recently discharged after an acute episode of Heart Failure with Preserved Ejection Fraction (HFpEF) requires a proactive and multifaceted approach. Implement a comprehensive discharge plan that includes careful medication reconciliation, detailed patient education about self-care, and close follow-up with a healthcare provider. Consider incorporating remote patient monitoring strategies, such as telehealth and wearable sensors, to detect early signs of decompensation. Explore how optimizing treatment for comorbidities, particularly hypertension, diabetes, and sleep apnea, can contribute to reducing readmission rates. Learn more about structured programs that emphasize patient engagement and support, such as disease management programs or heart failure clinics, as these can provide ongoing education and monitoring to improve long-term outcomes for patients with HFpEF.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.